Drugs / Fluzone IIV3
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02987374 Background | May → Dec 2012 | influenza | Stanford University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fluzone IIV3 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02987374 ↗ |
| Modality | Vaccine | “2011-2012 Fluzone IIV3 vaccine delivered intramuscularly (IM)” NCT02987374 ↗ |
| Route | Intramuscular | “All participants will receive a single dose of the current seasonal influenza vaccine by intramuscular (IM) injection at Day 0.” NCT02987374 ↗ |